Sponsor Monitoring and Auditing for Clinical Research Studies

For clinical research studies where a study sponsor is obligated by the FDA to monitor study source records, sponsors may now be provided monitoring capability through one of three mechanisms:

Remote monitoring through HealthLink (a module within UCLA’s CareConnect Electronic Health Records System) for CareConnect related source records, eBinders for regulatory documents, and UCLA’s secure instance of Box.com for source documents not stored in CareConnect;
Remote monitoring through UCLA’s secured instance of Zoom video conferencing facilitated by the principal investigator and research team; and/or
Safe and compliant on-site monitoring facilitated by the principal investigator & research team as outlined by the following procedures and/or policies (links may require UCLA AD login):

Remote monitoring through HealthLink requires both, a Remote Monitoring Agreement facilitated by Clinical Trial Contracting & Strategic Relations (CTC-SR), as well as budget allocations for applicable Remote Monitoring Set-Up and Provisioning Fees (referenced below) for each sponsor-monitor provisioned with remote monitoring access. The institutional remote monitoring agreement and applicable remote monitoring fees have been standardized to streamline remote monitoring setup and mitigate negotiation. The option for remote monitoring may be made available prospectively during contract negotiations for new clinical trial agreements received by CTC-SR as of October 1, 2020. For existing studies, a process has been established to prioritize study teams and sponsors requiring remote monitoring access with the limited resources available to support remote monitor contracting, set-up and provisioning. For more information, please contact CTSIORA@mednet.ucla.edu.

Remote monitoring of regulatory documents through eBinders requires budget allocations for applicable Remote Monitoring Set-Up and Provisioning Fees (referenced below) for each sponsor-monitor provisioned with remote monitoring access. The remote monitoring fees have been standardized to streamline remote monitoring setup and mitigate negotiation.

For source and study documents stored external to CareConnect, such documents should be redacted appropriately of participant Protected Health Information (PHI) and uploaded to UCLA secure Box.

Remote Monitoring for sponsors through Zoom is to be facilitated by the research team. Monitoring language in existing clinical trial agreements would typically not require modification to enable Zoom-based monitoring. Should you have industry clinical trial contract related questions please contact Tamika Merrick, Director of CTC-SR at TMerrick@mednet.ucla.edu.

On-site Monitoring has traditionally been the primary method for sponsor monitoring of clinical trials at UCLA. However, on-site monitoring should be limited to only rare instances when the remote monitoring arrangements referenced in (1) and (2) above cannot be achieved with sponsor(s).

On-site monitoring can occur in Non-UCLA Health System Space (Departmental or School) where the on-site monitoring access is deemed essential to comply with applicable laws and study teams and monitors strictly adhere to the appropriate UCLA health visitor requirements. Investigators must obtain Department Chair or Division Chief (or designee) written approval permitting the request for an on-site visit.

On-site monitoring can occur in UCLA Health System Space where the on-site monitoring access is deemed essential to comply with applicable laws and study teams and monitors strictly adhere to the appropriate UCLA Health vendor requirements. For visits in Health System Space, the study Principal Investigator must obtain Department Chair or Division Chief (or designee) written approval permitting the request for an on-site visit. In addition, approval must be obtained by contacting the CTSI Office of Regulatory Affairs. The monitor will need SEC³URE GO! access to enter UCLA Health System Space for their monitoring visit.
"UCLA Health System Space" is any location owned or operated by UCLA hospitals and/or UCLA outpatient clinics, managed by either the UCLA Hospital or UCLA Faculty Practice Group utilized to provide clinical care to UCLA patients. This includes, but is not limited to, Ronald Reagan UCLA Medical Center, Santa Monica Medical Center, UCLA Orthopaedic Surgery, Resnick Neuropsychiatric Hospital, ambulatory sites, and the UCLA Faculty Practice Group.

For research studies where a study sponsor is NOT obligated by the FDA to monitor/audit the study source records, sponsors are generally not allowed to conduct monitoring of study records. Sponsors may request a special exception with the Office of Compliance. If approved, sponsors may only conduct monitoring through the remote access process.

Remote Monitoring Fee Schedule (Direct Costs)	Remote Monitoring EHR Setup Fee (includes study setup and provisioning up to one monitor for both HealthLink and eBinders)	Remote Monitor EHR Setup Fee (each additional monitor) This covers both HealthLink and eBinders)	eBinders Only Remote Monitoring Setup Fee (includes study setup and provisioning up to one monitor for only eBinders)	eBinder Only Remote Monitor Setup Fee (each additional monitor) This covers only eBinders	Non-EHR, cloud-based remote monitoring setup (e.g. participant diaries, questionnaires, etc.)	Remote or On-Site Monitoring Visit Fee (applicable if UCLA faculty and/or staff visit participation is required)
Fee Classification	Required Pass-Thru	Required Pass-Thru	Required Pass-Thru	Required Pass-Thru	Guidance for Study Team Effort	Guidance for Study Team Effort
Per Study, Per Monitor, Per Visit	Per Study	Per Monitor	Per Study	Per Monitor	Per Study	Per Monitoring Visit
Industry Funded Clinical Research Study	$3,000	$2,250	$1,000	$500	$1,000-$2,500	$250-$500

"Please note: all fees above are subject to the applicable UCLA indirect rate(s)."

These rates apply to all NEW studies initiated within webIRB and BruinIRB as of March 1, 2024. For prior rates, please contact the CTSI ORA.

Remote monitoring set-up and provisioning fees may include, but are not limited to, facilitation of the following tasks:

Remote monitoring terms and obligations contract review and execution with study sponsor(s) and CRO(s) for each applicable clinical research study.
Study-specific statement of work defining scope and effective timeline for provisioning.
Individual study monitor terms and obligations agreement review and completion.
UCLA Healthlink Electronic Health Record (EHR) user access application review and completion.
Remote study monitor provisional access application completion.
Remote study monitor online training – scheduling, facilitation, and completion.
Remote study monitor approval and access provisioning.
Remote study monitor virtual visit scheduling and research participant linking to Healthlink.
Remote monitoring use and access compliance – tracking, auditing, maintenance and reporting.

Monitors may not in any way divulge, save, copy, print, record, photograph, download, export, screenshot, release, sell, loan, alter and/or destroy any PHI except as permitted by law and properly authorized by the policies of the Participant. Any breach of the responsibilities and/or conditions of the terms of access may be subject to access suspension, employer notification and disciplinary action, and may be subject to civil and/or criminal charges, as applicable. Reinstatement of suspended access will be subject to the requirements, training and fees associated with new user access, as determined at UCLA’s discretion.

Please see the “UCLA Clinical Research External Monitoring & Auditing Policy HS 9207” for more information.

For access to HealthLink and eBinders, once the Remote Monitoring Agreement has been executed with Clinical Trial Contracting & Strategic Relations (CTC-SR), please complete the following forms and submit them to the CTSI ORA:

For access to eBinders ONLY, please complete the following forms and submit them to the CTSI ORA:

Monitor eBinders Request Form
eBinders Training Certificate

*eBinders coming Spring 2024